SynAct Pharma

Lund, Sweden

SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.

$1.8M raised

Jul 2025

Post-IPO Equity

Biotechnology Health Care

Top Investors

Heights Capital Management EISMEA

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SynAct Pharma

How much funding has SynAct Pharma raised?

SynAct Pharma has raised $1.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.

Who are SynAct Pharma's investors?

SynAct Pharma's investors include Heights Capital Management, EISMEA.

Where is SynAct Pharma headquartered?

SynAct Pharma is headquartered in Lund, Sweden.

What does SynAct Pharma do?

SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.

What stage is SynAct Pharma at?

SynAct Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 15, 2025.

MLA

"SynAct Pharma — Funding & Investors." VCBacked, July 15, 2025, https://www.vcbacked.co/company/synact-pharma. Accessed July 3, 2026.

APA

VCBacked. (2025). SynAct Pharma — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/synact-pharma

Wikipedia (cite web)

{{cite web |title=SynAct Pharma — Funding & Investors |url=https://www.vcbacked.co/company/synact-pharma |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 15, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K